W8 Anticancer strategies Flashcards

1
Q

What are the 3 traditional approaches to the treatment of ca?

A

Surgery
Radiotherapy
Chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the novel approaches/terms to ca treatment? (7)

A
  • Immunotherapy
  • Anti-hormonal therapy (chemotherapy)
  • Targeted Chemotherapy (“Precision oncology”- chemotherapy)
  • Biosimilars
  • Epigenetic Therapy (chemotherapy)
  • Hyperthermic Chemotherapy (chemotherapy)
  • Photodynamic therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the Aims of cancer treatments? (3)

A

1-Curative: radical treatment to kill or remove all the cancer cells present
2-Control: stop cancer from progression to improve the length and quality of life
3-Palliation: reduce tumour load and improve symptoms (less aggressive approach)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A chemotherapeutic drug can be considered what..? (4)

A

1-Curative: radical treatment (high dose) to kill all the cancer cells present
2-Adjuvant: kill remaining cancer cells aftersurgery or radiation
3-Neoadjuvant: reduce tumour size before surgery or radiation
4-Palliative: treat but not aggressively to help symptom

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the Clinical events in the treatment of cancer?

A
  1. Screen vulnerable populations for the pre-
    malignant signs/early stages of some
    cancers (IDEAL). Patient detects symptoms
    and reports these to a doctor
  2. If diagnosis is confirmed → state of development of the cancer (staging)
    and the type of cancer is established
    → type of treatment
  3. Kill residual cancer cells and possible metastases
    * Regions of anatomical complexity or vital
    biological functions (head, neck, brain,spine) surgery would cause many problems →radiotherapy

See canvas flow diagram!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

1-Early detection means better results
Why is this?

A
  • Cancer can be physically detected → has been developing for a long time 1cm tumour has passed through three-quarters of its lifespan
  • More time= increased cellular change towards aggressiveness
  • The earlier a cancer can be detected, the fewer changes it will have undergone and
    the more likelihood there will be of getting a good response to treatment
  • Increased likelihood of achieving a cure when small numbers of cancer cells are present at the start of therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Early detection (for info)
Remission means how many cancer cells left in the body?

A

A cancer comprising 10^9 cells: only detectable by physical examination of patients

Relationship of Cell no to Pt status:
Detection: 10^8= 1cm3 most solid cancers reach cm3 before detection
Remission= 1mm3 means pt may still have 10^5 cells remaining!
Death= 10^12 cancer cells in body

  • Graph shows that screening campaigns (if possible) are fundamental

37 trillion cells in our bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2-Potential response to treatment
What is Relapse-free/ overall survival time?

A

To “Measure” a response and the effectiveness of treatments → patients informed about
the likely outcome of their treatments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Response to the treatment (usually 6 months) can be classified as what?: (6)

A
  • Cure: no evidence of disease for a minimum of 5 years
  • Complete response: cancer disappears completely (relapses still possible)
  • Partially response: disappears partially (tumour size reduced at list by 30%)
  • Clinical benefit: level of improvement is not reached; patient has experienced significant attenuation of symptoms and/or enhancement of quality of life
  • Stable disease: tumour size increased by < 20% or decreased by < 30%
  • Progressive disease: continues to grow (20% or higher level )
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

3-Patient criteria: stage and grade
What is this based on?
How many stages are there?

A
  1. Based on tumour size and degree of spread (stage of disease)

TNM system: based on the three criteria of Tumour size (T1 to T4), spread to the lymph Nodes (N0 to N3) and Metastasis to distant sites (M0 or M1)

Stage 1 (localised): small size that has not progressed outside its original site
stage 2 (local) and 3 (regional): intermediate disease severity
Stage 4 (metastatic): growth is large and has spread widely

Size: bigger size limits drug and oxygen delivery to large tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

3-Patient criteria: stage and grade

  1. Based on the cellular characteristics of the cancer (grade or histological grade)

What is a low grade vs high grade tumour?

A

How histologically similar is the tumour to the tissue of origin?

Criteria for grading: (compare ca cells to healthy orignal cells)
* Increasing anaplasia (poor cell differentiation + loss of morphology: irregularities in nuclear shape and resemblance to normal tissue.)
* Increasing mitotic activity (number of mitotes)
* Increasing genetic instability

Low-grade tumour: histological resemblance to the tissue of origin
High-grade tumour: undergone so many changes → resembles the tissue of origin only marginally

STAGE and GRADE : measure different parameters of the cancer and can be used to predict the likely course of the cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Surgery
What are the aims? (4)

A

Treatment for solid tumours, can result in a complete cure. Followed by adjuvant chemotherapy.

  • To remove the primary tumour
  • To remove accessible isolated metastases
  • To treat complications of cancer (hemorrhage, perforation, bowel obstruction, spinal cord compression)- Imaging techniques
  • Reconstruct anatomical defects to improve function, cosmetic appearance, QOF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Preventative surgery?
What is Pre-emptive surgery?

A

Preventative surgery: removal of precancerous lesions, abnormal moles, colon polyps, pre-invasive forms of cancer

Pre-emptive surgery: prevent the disease in few rare cancers with a strong familial basis. E.g.:
-Colectomy for young asymptomatic patients with familial adenomatous polypitis mastectomy for double homozygous carriers of the BRCA1 and BRCA2 genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Radiotherapy:
What is the aim?
How long it kill cancer cells?

A

Delivers a narrow beam of high-energy X-rays to a well-defined area of the body

Aim= Kill malignant cells by causing irreparable damage to their DNA→ cancer cells stop dividing or die→ they are broken down and removed by the body

Does not kill cancer cells right away: takes days or weeks of treatment before DNA is damaged enough for cancer cells to die (weeks or months after radiation)

Radiation doses are fractionated (delivered over a period of days):

  • Allows any damaged normal tissues to repair themselves
  • Tumour stem cells or quiescent G0 (not fully differentiated) cells: are resistant to radiotherapy
    After radiotherapy→ tumour stem cells become reoxygenated and start proliferating. New doses destroy the reactivated tumour cells.

Reoxygenation: oxygen is required for the generation of the free radicals necessary to produce full effectiveness (oxygen effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Radiotherapy:

What is external beam radiation therapy?
What is internal radiation therapy?
What is systemic therapy?

A
  • External beam radiation therapy: external machine aims radiation at cancer site
  • Internal radiation therapy: source of radiation is inserted inside the body
    -Brachytherapy: radiation from radioactive sources either placed close to or inserted in the tumour. Plastic-covered flexible iridium-131 wires can be inserted into tumours of the tongue, breast, brain and buccal mucosa
  • Systemic therapy: treatment 88travels in the blood to tissues** killing cancer cells

Represents a component of anti-cancer treatment for ~40% of all cancer patients
Adjuvant, neo-adjuvant, palliative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Chemotherapy definition (new)?

A

“A treatment that uses cytotoxic/cytostatic and
OTHER drugs that respectively kill malignant cells or prevent them from proliferating (stopping them from dividing)”

From broad-spectrum cytotoxic drugs to targeted drugs: can specifically target cancer cells but spare normal cells high potency and low toxicity

17
Q

Anticancer drugs can be divided into 2 main classes:

A
  1. Cytotoxic or chemotherapeutic drugs: most traditional anticancer drugs working by disrupting the function of DNA→ 1) act on DNA directly; 2) act indirectly by inhibiting the enzymes involved in DNA synthesis; 3) act on
    microtubule dynamics involved in mitosis
  2. Anticancer drugs acting on specific cancer proteins: include ALL the drugs against specific molecular targets that are abnormal or overexpressed in the cancer cells (molecular targeted therapeutics)
  • Anti-hormonal therapy
  • Epigenetic inhibitors
  • Kinase inhibitors
  • PARP inhibitors (targeting repairing mechanisms)
  • Proteasome inhibitors
  • Many others
18
Q

What is the rationale for chemotherapy:
What is the issue?

A

Selectively kill cancer cells without targeting normal cells
Issue: cancer cells are derived from normal cells → identifying targets unique to cancer cells is not easy

Most traditional anticancer drugs (cytotoxic)

  • Act against targets present in both types of cells → **Effectiveness/selectivity **dependent on drugs becoming more concentrated in cancer cells than normal cells
  • Cancer cells: generally growing faster than normal cells → accumulate nutrients, synthetic building blocks, and drugs more quickly

Issues:
-Not all cancer cells grow rapidly; cells in the centre of a tumour may be dormant and evade the effects of the drug
-Some normal cells in the body grow rapidly (bone marrow cells) → side effects

-Molecular targeted therapeutics: more selective, less side effects

19
Q

Factors affecting response to chemotherapy:
1. Growth fraction and location of tumour cells (cellular heterogeneity)
What is Extrinsic and Intrinsic resistance?

A
  • Sensitive Cell: in active cell cycle
  • Resistant Cell: in phase G0, can be killed once they enter cell cycle, or phase G1
  • Other: Potentially sensitive but too distant from blood vessel

Extrinsic resistance= potentially sensitive cells are resistant because of external factors

Intrinsic resistance (acquired)= cells can develop resistance against drugs to which they are exposed

20
Q

Factors affecting response to chemotherapy
1) Growth fraction and location of tumour cells (cellular heterogeneity)
Extrinsic resistance:

Part ll

A
  • Cells in G0/G1 are refractory to most treatments, compared with those in S or M
  • DNA synthesis takes up 1% of the cycle time, then only 1% of cells will be in the S phase at any moment and only 1% of cells will be sensitive to S-phase-specific drugs
  • Cell-cycle-specific effects and drugs
21
Q

Factors affecting response to chemotherapy
1) Growth fraction and location of tumour cells (cellular heterogeneity)
Extrinsic resistance:

Part lll

A
  • The further a cancer cell is from a blood vessel, the less likely it is to receive enough drug to kill it
  • Radiotherapy: generation of reactive oxygen species from O2 to damage the DNA → oxygen is delivered by the blood
  • Hypoxia increases with distance from a blood vessel, and so radiation sensitivity decreases with distance
  • Some areas of a tumour are well vascularised whereas others are not; poorly vascularised cells will be hardly affected by drugs.

Cancer stem cells: might exist that are inherently resistant to current anticancer agents → could explain the re-emergence of certain tumours

22
Q

1) Growth fraction and location of tumour cells (cellular heterogeneity)

Intrinsic resistance (acquired): developed resistance

Decreased drug uptake & Increased drug removal

A

A. Decreased drug uptake: decreased influx into the cell. E.g. resistance to methotrexate by loss of reduced folate carrier, the membrane protein
required to transport it into the cell

B. Increased drug removal: increased efflux from the cell. Increased level of P-glycoprotein= transmembrane protein that functions as an ATP-dependent
efflux pump. Different drugs can be removed by P-glycoprotein → multidrug resistance (MDR)

23
Q

What are the factors affecting response to chemotherapy:
Intrinsic resistance: (8)

Drug metabolism & Increased levels of targets:

A

C. Drug metabolism: decreased drug activating enzymes/increased drug
inactivating enzymes. E.g.
Alkylating agents: conjugated to glutathione by glutathione-S-transferase→
upregulation of this enzyme increases the rate of drug inactivation.
5FU and cytarabine are activated by phosphorylations, and the kinases
involved are downregulated by prolonged drug exposure.

D. Increased levels of targets: prolonged exposure to methotrexate causes
amplification of the gene for its target protein dihydrofolate reductase→
amplified genes are expressed so that insufficient drug is available to inhibit
all the dihydrofolate reductase

24
Q

What are the factors affecting response to chemotherapy:
Intrinsic resistance: (8)
(He skipped this)

A

E. Increased DNA repairing: Cells contain efficient mechanisms for repairing
damaged DNA. Increased activity of this complex series of processes
therefore minimises the biological effect of DNA damage caused by drugs
F. Altered affinity of target
G. An alternative metabolic pathway
H. Blood supply and sanctuary sites: poor blood supply results in inadequate
drug delivery.
Blood–brain barrier prevents drugs carried in the blood from reaching cancer
cells growing in the brain. These are called sanctuary sites

25
Q

What are the Factors affecting response to chemotherapy? (4)

A

1) Growth fraction and location of tumour cells (cellular heterogeneity)
2) Tumour stage, grade and spread: TNM, low or high grade
3) Health, age and pre-existing medical conditions:
4) Drug metabolism- many anticancer drugs require chemical or enzymatic
activation in either normal or tumour tissue→ Consider any disfunction…

26
Q

How does Health, age and pre-existing medical conditions affect response to chemotherapy?

A
  • Aggressive cytotoxic therapy: debilitating →not suitable for old/frail individuals
  • Liver disease: altered drug metabolism and serum binding proteins
  • Anaemia & Immune disorders: cytotoxic chemotherapeutics exacerbate condition
  • Kidney disease: drug excretion, toxicity problems
  • Lung and Heart disease: precludes use of certain drugs
27
Q

Side Effects:
What are the common SE of chemotherapy?

A

Non-specific drugs (especially cytotoxic drugs): modulate general functions
(e.g. proliferation)→ affects proliferating cells throughout the body→ side effects

Cytotoxic drugs: cancer cells can have
increased levels of proliferation (faster),
→ respond to lower doses of some drugs,
but side effects will still occur

New treatments: increasing specificity by targeting drugs preferentially to cancer cells

Common side effects
* Anaemia: haemopoietic cells are particularly sensitive to cytotoxic drugs; can be treated either with blood transfusions or erythropoietin
* Reduced white blood cell numbers (neutropenia): decreased resistance to
infection; can be treated with either antibiotics or G-CSF/GM-CSF treatment
* Nausea and vomiting: common side effects; the drugs involved activate vomiting
centres in the brain stem; these effects can be alleviated by 5-hydroxytryptamine receptor antagonists or corticosteroids.

28
Q

How can SE be minimised? (3)

A
  • Carefully dosing the drug (especially cytotoxic drugs)
  • Using combinations of drugs with different toxicities (combination or polychemotherapy)
  • Using supportive procedures

During treatment, the target cells may become resistant to the drugs used, and
so many chemotherapists prefer to use high doses initially in the hope of killing all the malignant cells before resistance develops

29
Q

Combination Therapy
Why is it favoured?

A

o Single drug treatments: can be effective but not preferred (resistance)
o Combination therapy is used in all cancers: higher clinical success
o Different combinations are used for different cancers; each combination is given an acronym (CHOPP, VAD, MOPP, CMF, etc.)
o Cells develop different types of resistance to each of these compounds →combination increases the likelihood that one of the drugs will be effective on the cells
o Each drug has its own toxicity profile, and thus individual toxicities can be minimised without diminishing the overall cytotoxic effect

Efficacy: find the right balance between activity (different targets, MoA, resistance) and safety (compatible side effects in different organ

30
Q

Combination Therapy
Use combinations of drugs that?

A

o Active against the tumour type
o Act on different targets
o Act at different phases of the cell cycle
o Effect different organs and tissues (avoid to overload a single organ/tissue)
o Have minimum or no overlapping toxicity
o Are optimum for each drug with consistent timing of the doses
o Therapy cycles dictated by bone marrow recovery: Bone marrow toxicity is the
main dose limiting factor